CLASS II Drug recall · Reported 25 Jun 2014 · FDA Enforcement Report
Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg recalled
Thorne Research is recalling Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, distributed nationwide in the US. The recall was initiated on 12 Jun 2014 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1384-2014
- FDA event ID
- 68222
- Recalling firm
- Thorne Research, Sandpoint, ID
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 12 Jun 2014
- FDA classified
- 13 Jun 2014
- Reported
- 25 Jun 2014
- Type
- Voluntary: Firm initiated
- Customers notified by
- Visit
- Reason category
- Hidden Drug Ingredients
Timeline
| 12 Jun 2014 | Recall initiated by company | |
| 13 Jun 2014 | Classified by FDA | +1 day |
| 25 Jun 2014 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.
Products marketed as supplements sometimes contain undeclared prescription drug ingredients such as sildenafil or sibutramine. These can interact dangerously with other medicines.
Product as listed by the FDA
Captomer-250 [succinic acid (from 250 mg DMSA)] capsules, 162 mg, 45-count bottles, Manufactured By: Thorne Research, Inc., P.O. Box 25, Dover, Idaho 83825, UPC 6 93749 73502 1
Where it was distributed
Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.
Questions about this recall
Why was it recalled?
Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.
Which lots are affected?
All lot codes
Where was it sold?
Nationwide, New Zealand, England, German, Sweden, Ukraine, and Egypt.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 68222| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg recalled | Thorne Research | Hidden Drug Ingredients | Nationwide |
More recalls from Thorne Research
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Captomer [succinic acid (from 100 mg DMSA)] capsules, 65 mg recalled | Thorne Research | Hidden Drug Ingredients | Nationwide |